問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Tri-Service General Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2021-08-01 - 2023-12-31
Condition/Disease
Test Drug
Participate Sites8Sites
Terminated8Sites
2021-06-01 - 2023-12-31
Participate Sites4Sites
Recruiting4Sites
2019-11-01 - 2026-09-07
Mantle Cell Lymphoma / Non-Hodgkin Lymphoma
Zanubrutinib (BGB-3111)
Participate Sites3Sites
Recruiting3Sites
2004-01-01 - 2006-12-31
Participate Sites2Sites
Terminated2Sites
2004-02-01 - 2005-02-01
2008-04-01 - 2010-12-31
Terminated4Sites
2008-04-01 - 2010-04-30
Participate Sites1Sites
Terminated1Sites
2008-05-05 - 2008-06-19
2007-01-16 - 2008-09-09
2010-06-01 - 2013-12-31
Participate Sites12Sites
Terminated12Sites
全部
